EC Number | Application | Comment | Organism |
---|---|---|---|
1.3.1.9 | medicine | tuberculosis, TB, target of anti-tubercular agents | Mycobacterium tuberculosis |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
1.3.1.9 | I16T | isoniazid resistant clinical mutant, in silico constructed | Mycobacterium tuberculosis |
1.3.1.9 | I21V | isoniazid resistant clinical mutant, in silico constructed | Mycobacterium tuberculosis |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.3.1.9 | 0.056 | - |
NADH | wild type enoyl-ACP reductase | Mycobacterium tuberculosis | |
1.3.1.9 | 0.104 | - |
NADH | I21V mutant enoyl-ACP reductase | Mycobacterium tuberculosis | |
1.3.1.9 | 0.149 | - |
NADH | I16T mutantwild type enoyl-ACP reductase | Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.3.1.9 | acyl-[acyl-carrier protein] + NAD+ | Mycobacterium tuberculosis | - |
trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+ | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.3.1.9 | Mycobacterium tuberculosis | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.3.1.9 | acyl-[acyl-carrier protein] + NAD+ | - |
Mycobacterium tuberculosis | trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+ | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.3.1.9 | enoyl reductase | - |
Mycobacterium tuberculosis |
1.3.1.9 | enoyl-ACP reductase | - |
Mycobacterium tuberculosis |
1.3.1.9 | enoyl-[acyl-carrier-protein] reductase | - |
Mycobacterium tuberculosis |
1.3.1.9 | InhA | - |
Mycobacterium tuberculosis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.9 | NADH | - |
Mycobacterium tuberculosis |